THERAPEUTIC PRODUCT EFFECT INCOMPLETE

This adverse event was reported 71208 times

These drugs are most commonly taken by patients reporting THERAPEUTIC PRODUCT EFFECT INCOMPLETE:

# Drug Count
0 PREDNISONE 10626
1 ADALIMUMAB 8095
2 METHOTREXATE SODIUM 7869
3 METHOTREXATE 6755
4 TOFACITINIB 6273
5 ALBUTEROL SULFATE 5642
6 SECUKINUMAB 5146
7 MEPOLIZUMAB 5092
8 ETANERCEPT 4704
9 ACETAMINOPHEN 4088
See all common drugs associated with THERAPEUTIC PRODUCT EFFECT INCOMPLETE

THERAPEUTIC PRODUCT EFFECT INCOMPLETE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INFLIXIMAB-DYYB 849 0.2464
1 CICLESONIDE 2612 0.1901
2 GOLIMUMAB 2290 0.1818
3 AZATHIOPRINE SODIUM 323 0.1274
4 NICOTINAMIDE 303 0.1186
5 ERGOCALCIFEROL 3524 0.1185
6 GOLD 683 0.1176
7 MEPOLIZUMAB 5092 0.1010
8 MINOCYCLINE HYDROCHLORIDE 476 0.0803
9 PSEUDOEPHEDRINE HCL 734 0.0671
See all drugs enriched for association with THERAPEUTIC PRODUCT EFFECT INCOMPLETE

THERAPEUTIC PRODUCT EFFECT INCOMPLETE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthracycline Topoisomerase Inhibitor [EPC] 217 0.0893
1 Provitamin D2 Compound [EPC] 1735 0.0583
2 Aminosalicylate [EPC] 4291 0.0426
3 Antihypoglycemic Agent [EPC] 177 0.0413
4 Antirheumatic Agent [EPC] 3960 0.0374
5 Sulfonamide Antibacterial [EPC] 134 0.0335
6 Interleukin-36 Receptor Antagonist [EPC] 12 0.0298
7 Dopamine-2 Receptor Antagonist [EPC] 229 0.0294
8 Leukotriene Receptor Antagonist [EPC] 845 0.0289
9 beta3-Adrenergic Agonist [EPC] 1358 0.0284
See all drug classes enriched for association with THERAPEUTIC PRODUCT EFFECT INCOMPLETE